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Nonetheless, perhaps the authors could map out these global 
and local causes of  delay in a generic Ishikawa fishbone 
diagram. First created by Kaoru Ishikawa in a management 
setting back in 1968, the fishbone diagram is a useful 
management tool in brainstorming and identifying the possible 
causes for an effect or a problem.[4] Ishikawa fishbone diagram 
aids in sorting out causes of  an effect into broad categories 
that can be easily memorized by the 8 Ms, viz., manpower, 
machine  (technology),	 methods,	 material  (e.g.,  drugs),	
measurement  (e.g.,  investigation	modalities),	 the	milieu  (or	
environment), management pathway, and money.[4] For 
example, the rural locality identified as a cause of  prehospital 
delay	in	this	study	can	be	grouped	as	a	milieu (environment)	
cause whereas the use of  public transportation is a machine 
cause. However, there are perhaps other causes that are not 
entirely clear under which category of  causes they result in 
the delay. For example, exactly why the absence of  a previous 
history of  diabetes mellitus results in prehospital delay? 
Exactly, why the symptom misinterpretation and symptom 
onset at home contribute to this delay?
This is perhaps due to the fact that we have not been asking 
deeper questions. Sakichi Toyoda of  the Toyota Motor 
Corporation says that to get to the bottom of  a problem, one 
should keep asking why iteratively with each question forms 
the	basis	for	the	next,	up	to	5 times (as	a	rule	of 	thumb).	This	
is known as the “5 Whys” approach in root cause analysis.[5] 
Although not a hard-and-fast rule, the principle is, most people 
deliver a quick fix to a problem by dealing with causes that 
maybe immediately apparent but are not the most important 
ones. In this regard, symptom misinterpretation and symptom 
onset at home are identified as causes of  prehospital delay 
in receiving reperfusion therapy. One should then ask why 
symptom misinterpretation is a cause of  delay? An obvious 
postulation could be that it is due to the lack of  patient 
education. However, if  that is really the case, one should not 
just stop at this juncture. Rather, one should continue asking, 
why is there a lack of  patient education? By probing deeper 
and deeper, one would probably get to the root cause or causes 
of  the problem, and would then be able to categorize under 
which groups in the Ishikawa fishbone diagram do these factors 
belong to.
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Due to its ubiquitous occurrence, acute coronary syndrome is 
a global health problem. The necessity for early transportation 
to a facility with reperfusion strategies is well established 
given the fact that delay of  reperfusion is associated with 
increasing mortality and morbidity.[1] The American College 
of 	Cardiology	Foundation  (ACCF)	 and	 the	American	Heart	
Association  (AHA)	 advocate	 that	 patients	with	 ST‑elevation	
myocardial	 infarction  (STEMI)	 as	 well	 as	 non‑STEMI	
to be transported via ambulances rather than using own 
transportation.[1,2] Eight reasons are listed in the ACCF/AHA 
2013 guideline on why patients delay in seeking treatment for 
STEMI.[1]	 These	 are  (1)	 atypical	 symptoms	 presentation,  (2)	
inappropriate reasoning that the symptoms experienced are 
not	 serious,  (3)	 attribution	of 	 symptoms	 to	other	preexisting	
conditions,  (4)	fear	of 	embarrassment	should	symptoms	turn	
out	to	be	a	“false	alarm,” (5)	reluctance	to	trouble	others	unless	
they	 are	 “really	 sick,”  (6)	 preconceived	 stereotypes	 of 	 how	 a	
heart	 attack	 patient	 should	 look	 like,  (7)	 lack	 of 	 knowledge	
of  the importance of  rapid action, the benefits of  calling for 
reperfusion	therapies	and (8)	attempted	self‑treatment	to	relieve	
the symptoms.[1] As such, one may wonder is there any additional 
value of  publishing yet another study on the causes of  prehospital 
delay to reperfusion strategy in STEMI.
Nonetheless, in this study, the authors must be applauded for 
showing that besides the well-established contributing factors, 
there are a number of  local and regional variations in South India 
that may further exaggerate the delay in receiving reperfusion 
therapy.[3] For example, the authors show that patients who are 
staying in rural areas, patients with no past history of  diabetes 
mellitus, patients with difficulty in arranging money, patients who 
are	being	transported	using	public	transportation (as	opposed	to	
using ambulances) are among the patients who are significantly 
more likely to experience delay in receiving reperfusion therapy.
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In summary, tackling the problem of  prehospital delay in receiving 
reperfusion therapy in STEMI may not be as straightforward as 
described	 in	 textbooks	 and	 journals.	A number	 of 	 local	 and	
regional variations in national healthcare delivery system, clinical 
management pathways, sociocultural factors, economic factors, 
etc., must taken into consideration. In other words, although 
acute coronary syndrome is a global health problem, a glocal 
approach is perhaps more appropriate in addressing this problem.
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